BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18585004)

  • 21. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of the oncoprotein prothymosin alpha triggers a p53 response that involves p53 acetylation.
    Kobayashi T; Wang T; Maezawa M; Kobayashi M; Ohnishi S; Hatanaka K; Hige S; Shimizu Y; Kato M; Asaka M; Tanaka J; Imamura M; Hasegawa K; Tanaka Y; Brachmann RK
    Cancer Res; 2006 Mar; 66(6):3137-44. PubMed ID: 16540664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity.
    Chen K; Liu J; Liu S; Xia M; Zhang X; Han D; Jiang Y; Wang C; Cao X
    Cell; 2017 Jul; 170(3):492-506.e14. PubMed ID: 28753426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing.
    Zhu K; Lei PJ; Ju LG; Wang X; Huang K; Yang B; Shao C; Zhu Y; Wei G; Fu XD; Li L; Wu M
    Nucleic Acids Res; 2017 Jan; 45(1):92-105. PubMed ID: 27614073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
    Skucha A; Ebner J; Grebien F
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30818762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shaping the cellular landscape with Set2/SETD2 methylation.
    McDaniel SL; Strahl BD
    Cell Mol Life Sci; 2017 Sep; 74(18):3317-3334. PubMed ID: 28386724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.
    Zhou Y; Zheng X; Xu B; Deng H; Chen L; Jiang J
    Aging (Albany NY); 2020 Nov; 12(24):25189-25206. PubMed ID: 33223508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac transcription factor Nkx2.5 interacts with p53 and modulates its activity.
    Kojic S; Nestorovic A; Rakicevic L; Protic O; Jasnic-Savovic J; Faulkner G; Radojkovic D
    Arch Biochem Biophys; 2015 Mar; 569():45-53. PubMed ID: 25677450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2.
    Eram MS; Kuznetsova E; Li F; Lima-Fernandes E; Kennedy S; Chau I; Arrowsmith CH; Schapira M; Vedadi M
    Biochim Biophys Acta; 2015 Sep; 1850(9):1842-8. PubMed ID: 26002201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F1 inhibits MDM2 expression in a p53-dependent manner.
    Tian X; Chen Y; Hu W; Wu M
    Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer.
    Lin RK; Wu CY; Chang JW; Juan LJ; Hsu HS; Chen CY; Lu YY; Tang YA; Yang YC; Yang PC; Wang YC
    Cancer Res; 2010 Jul; 70(14):5807-17. PubMed ID: 20570896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth.
    Zhao Z; Wu L; Shi H; Wu C
    Mol Med Rep; 2014 May; 9(5):1903-8. PubMed ID: 24584189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of Histone Methyltransferase SET Domain-Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC.
    Li XJ; Li QL; Ju LG; Zhao C; Zhao LS; Du JW; Wang Y; Zheng L; Song BL; Li LY; Li L; Wu M
    Hepatology; 2021 May; 73(5):1797-1815. PubMed ID: 33058300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.
    Ding Y; Lee JF; Lu H; Lee MH; Yan DH
    Mol Cell Biol; 2006 Mar; 26(5):1979-96. PubMed ID: 16479015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of SETD2 stability is important for the fidelity of H3K36me3 deposition.
    Bhattacharya S; Workman JL
    Epigenetics Chromatin; 2020 Oct; 13(1):40. PubMed ID: 33023640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The methyltransferase SETD2 couples transcription and splicing by engaging mRNA processing factors through its SHI domain.
    Bhattacharya S; Levy MJ; Zhang N; Li H; Florens L; Washburn MP; Workman JL
    Nat Commun; 2021 Mar; 12(1):1443. PubMed ID: 33664260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts.
    Yi X; Tao Y; Lin X; Dai Y; Yang T; Yue X; Jiang X; Li X; Jiang DS; Andrade KC; Chang J
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):697-707. PubMed ID: 28130125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
    Moumen A; Masterson P; O'Connor MJ; Jackson SP
    Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.